v3.26.1
Earnings (loss) per share - Schedule of Earnings per Share (Detail) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]      
Net income (loss) attributable to Teva's ordinary shareholders $ 1,410 $ (1,639) $ (559)
Weighted average shares outstanding 1,145 1,131 1,119
Basic earnings (loss) attributable to Teva's ordinary shareholders $ 1.23 $ (1.45) $ (0.5)
Diluted effect of stock options, RSUs and PSUs 17    
Total dilutive shares outstanding 1,163 1,131 1,119
Diluted earnings (loss) attributable to Teva's ordinary shareholders $ 1.21 $ (1.45) $ (0.5)